More on BHVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+62.8% Growth)
- Ratings (6.4 Score)
- Holders
- Event Driven Deals

Upcoming Events

- Earnings (11/17/26)
- M&A (3/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Biohaven Pharma (NY:BHVN)
Delayed: 13.88 -0.81 (5.51%)
Prev. Close $14.69  
Open$15.22 
52 Wk High$ 
52 Wk Low$ 
Day High$15.37 
Day Low$13.83 
P/E N/A  
EPS$ 
Volume4,690,219 

Friends, Peers and Foes (?): QURE, PTCT, WVE, XENE, CAPR (more...)

Oct 23, 2026 08:28 AM Biohaven Pharma (BHVN) PT Raised to $22 at RBC Capital
Oct 22, 2026 03:05 PM Biohaven Pharma (BHVN) January 17.5 calls active, share price up 23.9%
Oct 22, 2026 09:59 AM Increasing unusual option volume: BHVN MAT CHGG TBT QGEN GFL ALLY LION GTM ZURA LBRT FITB OPTU KNX
Oct 22, 2026 09:06 AM Biohaven Pharma (BHVN) PT Raised to $48 at Baird
Oct 22, 2026 07:20 AM Biohaven stock surges 25% on FDA acceptance of drug filing
Oct 22, 2026 07:06 AM FDA accepts Biohaven's troriluzole NDA resubmission for rare disease
Oct 22, 2026 07:00 AM Form 8-K Biohaven Ltd. For: Oct 22
Oct 15, 2026 05:19 PM Form 8-K Biohaven Ltd. For: Oct 08
Oct 9, 2026 07:05 AM Canaccord Reiterates Buy Rating on Biohaven Pharma (BHVN)
Oct 8, 2026 09:52 AM Citi reiterates Buy rating on Biohaven Pharma after licensing deal
View All Articles

Entities mentioned with BHVN

View All Entities